Hikal is a partner to companies in the Pharmaceuticals, Crop Protection, and Specialty Chemicals industry. The company is in the business of supplying research services, active ingredients, and intermediates for its customers
Technically Inputs
A volume Spike has been observed for the last few days
Price action is forming Higher Lows.
A Re-test of the price and then there can be a bounce for 1:4 target.
Financial Inputs
Q-o-Q Sales have increased from 338 to 377, and the Overall Profit margin has decreased from 26% to 14% hence this stock can be considered for Swing Investment.
Only for observation
Technically Inputs
A volume Spike has been observed for the last few days
Price action is forming Higher Lows.
A Re-test of the price and then there can be a bounce for 1:4 target.
Financial Inputs
Q-o-Q Sales have increased from 338 to 377, and the Overall Profit margin has decreased from 26% to 14% hence this stock can be considered for Swing Investment.
Only for observation
עסקה פעילה:
Met a resistance, hopefully if the volume comes then it will achieve the target 1 or will have to exit at the cost.